Order Article Reprints

İcli MC, Guven DC, Akyildiz A, Gürbüz AF, Majidova N, Kıdı MM, Kosku H, Sahin E, Gunes TK, Seyyar M, et al. Efficacy, Safety, and Survival Outcomes of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient Colorectal Cancer: A Retrospective, Multicenter Study. Journal of Clinical Medicine. 2026; 15(4):1554. https://doi.org/10.3390/jcm15041554

İcli, Mehmet Cihan, Deniz Can Guven, Arif Akyildiz, Ali Fuat Gürbüz, Nargiz Majidova, Mehmet Mutlu Kıdı, Hakan Kosku, Elif Sahin, Tugce Kubra Gunes, Mustafa Seyyar, and et al. 2026. "Efficacy, Safety, and Survival Outcomes of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient Colorectal Cancer: A Retrospective, Multicenter Study" Journal of Clinical Medicine 15, no. 4: 1554. https://doi.org/10.3390/jcm15041554

İcli, M. C., Guven, D. C., Akyildiz, A., Gürbüz, A. F., Majidova, N., Kıdı, M. M., Kosku, H., Sahin, E., Gunes, T. K., Seyyar, M., Almuradova, E., Sancı, P. C., Bilgin, B., Kara, I. O., Artac, M., Dizdar, Ö., & Yalcin, S. (2026). Efficacy, Safety, and Survival Outcomes of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient Colorectal Cancer: A Retrospective, Multicenter Study. Journal of Clinical Medicine, 15(4), 1554. https://doi.org/10.3390/jcm15041554